Skip to Content

Natazia Approval History

Natazia (dienogest and estradiol valerate) is a combination oral contraceptive indicated for use by women to prevent pregnancy and to treat heavy menstrual bleeding.

Development History and FDA Approval Process for Natazia

DateArticle
Mar 15, 2012Approval U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB)
May  7, 2010Approval FDA Approves Natazia - New Combination Product Oral Contraceptive
Jul  8, 2009Bayer submits first-in-class estradiol-based oral contraceptive for approval in the U.S.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide